Lotte Biologics said it has signed a memorandum of understanding (MOU) with Asimov, a Boston-based biotechnology company, to collaborate on contract development and manufacturing organization (CDMO) services.Under the agreement, Lotte Biologics will leverage Asimov's next-generation cell line develo
Asimov is a Massachusetts-based health-tech platform that offers genetic engineering framework and living cell programming solutions for the healthcare sector.